Health Exact Sciences (EXAS) Crossed Above the 20-Day Moving Average: What That Means for Investors December 19, 2022
Health Biogen Reaches Agreement with Genentech to Receive Royalties on the Potential Commercialization of a Late-Stage Bispecific Antibody as Part of Anti-CD20 Collaboration December 19, 2022
Tech SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HZNP, COUP, FRBA, MLVF December 18, 2022
Health U.S. FDA Approves VRAYLAR® (cariprazine) as an Adjunctive Treatment for Major Depressive Disorder December 16, 2022
Search
Search
